FDA Fast Track

BOCA RATON, Fla., August 6, 2026 INmune Bio Inc. reported its second quarter 2026 financial results while highlighting significant...

BRISBANE, Calif., August 6, 2026 Annexon, Inc. announced encouraging early clinical results from the ongoing FORWARD open-label study, with...

NANTONG, China, July 29, 2026 Ractigen Therapeutics has successfully closed a financing round exceeding $31 million (over RMB 200...

HOUSTON, July 31, 2026 Moleculin Biotech, Inc. announced updated positive preliminary blinded interim results from Part A of its...

DALLAS, July 27, 2026 CG Oncology, Inc. announced the publication of results from its pivotal Phase 3 BOND-003 Cohort...

New Haven, Connecticut, July 27, 2026 Yarrow Bioscience, Inc. announced the successful completion of its merger with VYNE Therapeutics...

RESEARCH TRIANGLE PARK, N.C., July 21, 2026 Merakris Therapeutics announced that it has received a Direct-to-Phase II Small Business...

REDWOOD CITY, Calif., July 21, 2026 Pheast Therapeutics announced the publication of peer-reviewed preclinical data in Clinical Cancer Research,...

San Diego, California, USA | July 21, 2026 Acadia Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA)...

SAN DIEGO, July 20, 2026 Oncolytics Biotech announced that the U.S. Food and Drug Administration (FDA) has granted Fast...